Synaptec Ltd - Accounts to registrar (filleted) - small 23.1.2
Synaptec Ltd - Accounts to registrar (filleted) - small 23.1.2
| REGISTERED NUMBER: |
| Financial Statements for the Year Ended 31 December 2022 |
| for |
| Synaptec Ltd |
| Synaptec Ltd (Registered number: SC472060) |
| Contents of the Financial Statements |
| for the Year Ended 31 December 2022 |
| Page |
| Company Information | 1 |
| Statement of Financial Position | 2 |
| Notes to the Financial Statements | 3 |
| Synaptec Ltd |
| Company Information |
| for the Year Ended 31 December 2022 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| 227 West George Street |
| Glasgow |
| G2 2ND |
| Synaptec Ltd (Registered number: SC472060) |
| Statement of Financial Position |
| 31 December 2022 |
| 31.12.22 | 31.12.21 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| Investments | 5 |
| CURRENT ASSETS |
| Stocks | 6 |
| Debtors | 7 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 8 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
9 |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 11 |
| Share premium |
| Share based payments reserve | 12 |
| Retained earnings | ( |
) | ( |
) |
| SHAREHOLDERS' FUNDS |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Synaptec Ltd (Registered number: SC472060) |
| Notes to the Financial Statements |
| for the Year Ended 31 December 2022 |
| 1. | STATUTORY INFORMATION |
| Synaptec Ltd is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group. |
| Turnover |
| Turnover represents income from the sale of the company's products and is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business. Turnover is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably. |
| Where product sales include predetermined milestones such as product testing or installation, turnover is recognised on completion of these milestones. |
| Tangible fixed assets |
| Tangible fixed assets are stated at historical cost less accumulated depreciation and any impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. |
| Depreciation is charged to profit or loss over the estimated useful life economic lives as follows- |
| -Plant and machinery- Over 5 years on straight line basis |
| -Computer and equipment- 33% on cost. |
| Basic financial liability |
| Basic financial liabilities, including certain creditors and other loans, are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortized. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. |
| Investments in subsidiaries |
| Investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals or impairment losses are recognised immediately in the profit and loss account. |
| Stocks |
| Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost includes expenditure incurred in acquiring the stocks, production or conversion costs and other costs in bringing them to their existing location and condition . |
| At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its estimated selling price less costs to complete and sell. The impairment is recognized immediately within profit and loss. |
| Synaptec Ltd (Registered number: SC472060) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2022 |
| 2. | ACCOUNTING POLICIES - continued |
| Classification of financial liabilities |
| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. |
| Research and Development tax credits are recognised at the fair value of the asset received or receivable when there is reasonable assurance that claims will be successful. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Research and development |
| Expenditure on research and development is written off in the year in which it is incurred. |
| Foreign currencies |
| Transactions in foreign currencies are translated to the company's functional currency at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are retranslated to the functional currency at the foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are recognized in profit or loss. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| Government grants |
| Government grants are recognsied at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. |
| Government grants relating to turnover are recognised as income over the periods when the related costs are incurred. |
| Synaptec Ltd (Registered number: SC472060) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2022 |
| 2. | ACCOUNTING POLICIES - continued |
| Going concern |
| The directors believe the company has adequate resources to continue in operational existence for the foreseeable future, being a period of at least 12 months from the signing of the financial statements. |
| In forming this assessment, the directors have considered existing company resources as well as trading and cash flows projections. The company is entering a scale-up phase that will require additional investment to achieve its strategic objectives. The timing at which future investment is required could be within the next 12 months. Whilst there are no guarantees that investment could be raised within the next 12 months, the directors are confident they can manage the pace of scale-up and continue to meet the company's financial obligations from existing cash reserves in the event no additional investment is raised in the next 12 months. |
| Based on the factors above, the directors deem it appropriate to continue to prepare the financial statements on a going concern basis. |
| Share-based payments |
| Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted. Where material, the fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Plant and | Computer |
| machinery | equipment | Totals |
| £ | £ | £ |
| COST |
| At 1 January 2022 |
| Additions |
| At 31 December 2022 |
| DEPRECIATION |
| At 1 January 2022 |
| Charge for year |
| At 31 December 2022 |
| NET BOOK VALUE |
| At 31 December 2022 |
| At 31 December 2021 |
| Synaptec Ltd (Registered number: SC472060) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2022 |
| 5. | FIXED ASSET INVESTMENTS |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 January 2022 |
| and 31 December 2022 |
| NET BOOK VALUE |
| At 31 December 2022 |
| At 31 December 2021 |
| Synaptec Ltd is the ultimate group holding company of the Synaptec Group. Synaptec Ltd has one wholly owned subsidiary, Synaptec Instruments Ltd SC684349, registered in Scotland. Synaptec Instruments Ltd is currently dormant. |
| 6. | STOCKS |
| 31.12.22 | 31.12.21 |
| £ | £ |
| Stocks |
| 7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.12.22 | 31.12.21 |
| £ | £ |
| Trade debtors |
| Other debtors |
| Accrued income | 96,512 | 116,606 |
| Tax |
| VAT |
| Prepayments |
| 8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.12.22 | 31.12.21 |
| £ | £ |
| Trade creditors |
| Social security and other taxes |
| Other creditors |
| Accruals and deferred income |
| 9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 31.12.22 | 31.12.21 |
| £ | £ |
| Other loans (see note 10) |
| Accruals and deferred income |
| Synaptec Ltd (Registered number: SC472060) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2022 |
| 10. | LOANS |
| An analysis of the maturity of loans is given below: |
| 31.12.22 | 31.12.21 |
| £ | £ |
| Amounts falling due between two and five years: |
| Other loans - 2-5 years |
| 11. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 31.12.22 | 31.12.21 |
| value: | £ | £ |
| Ordinary | £0.00 | 1 | 284 | 239 |
| The company operates an equity settled EMI Share Option Scheme. During the year, 1,869 (2021 - 1,100) share options were granted to employees by the company. At 31 December 2022, the total number of options outstanding under the scheme was 10,083 (2021 - 8,214) with an exercise price ranging between £12.48 and £37.28. The share options vest on their grant date but can only be exercised on certain exit events or at the discretion of the board. |
| 12. | RESERVES |
| Share |
| based |
| payments |
| reserve |
| £ |
| At 1 January 2022 | 83,758 |
| Credit to equity for equity settled share based payment transactions |
73,056 |
| At 31 December 2022 | 156,814 |
| 13. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
| The Report of the Auditors was unqualified. |
| for and on behalf of |